Technology of delivery of oncolyticviruses by immune cells
MAJOR CANDIDATE Legal data Possible Advantages Doesn’t cause severe side effects. Could potentially be targeted to several types of cancer. It can potentially become a platform for the creation of new (more effective) virus strains. Disadvantages Patent of 2017. Possibly should be used with other recognized treatments. Partial lysis of cancer cells, i.e., does not […]
Herpes Virus (IL12 expressing)
MAJOR CANDIDATE Legal data Possible Advantages Doesn’t cause severe side effects. Could potentially be targeted to several types of cancer. It can potentially become a platform for the creation of new (more effective) virus strains. Disadvantages Patent of 2017. Possibly should be used with other recognized treatments. Partial lysis of cancer cells, i.e., does not […]
Herpes Virus (IL15 expressing)
MAJOR CANDIDATE Legal data Possible Advantages Doesn’t cause severe side effects. Could potentially be targeted to several types of cancer. It can potentially become a platform for the creation of new (more effective) virus strains. Disadvantages Patent of 2017. Possibly should be used with other recognized treatments. Partial lysis of cancer cells, i.e., does not […]
Oncolytic Coxsackievirus
WHAT IS The Coxsackie Group B3 Virus Strain CVB3 PD-0 Possible Advantages Doesn’t cause severe side effects. Could potentially be targeted to several types of cancer. It can potentially become a platform for the creation of new (more effective) virus strains. Disadvantages Patent of 2017. Possibly should be used with other recognized treatments. Partial lysis […]
